Filament Health Ownership
FLHLF Stock | USD 0.04 0.01 31.33% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Filament |
Filament OTC Stock Ownership Analysis
About 66.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Filament Health Corp recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants conducts genetic research performs extraction procedures runs in-house trials and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. Filament Health is traded on OTC Exchange in the United States.The quote for Filament Health Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Filament Health Corp check out https://filament.health.Currently Active Assets on Macroaxis
Other Information on Investing in Filament OTC Stock
Filament Health financial ratios help investors to determine whether Filament OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Filament with respect to the benefits of owning Filament Health security.